myBMI Weight Loss Review | UK-Regulated GLP-1 Care

Losing weight shouldn’t feel like banging my head against a wall, but that’s how it’s been. GLP-1s like Wegovy® and Mounjaro® finally offer hope, yet choosing a clinic is its own minefield.

I’ve seen the Price-Safety Trap first-hand: cheap options that feel risky, expensive ones that promise more than they give.

That’s why I’m reviewing myBMI. It’s a UK-regulated, pharmacist-led clinic. I’ll cover how it works, pricing, and whether it’s worth trusting for weight loss.

---

📋Our Score: 3/5

myBMI’s pharmacist prescribers are weight-loss specialists, though not physicians, and costs rise with higher doses.

Pricing is fair for brand-name medications, and the educational resources are genuinely helpful. Still, limited lifestyle support, no app, and unresponsive customer service kept me from rating it higher.

Category	Rating
Results	★★★☆☆
Ease of use	★★★☆☆
Medical expertise	★★★☆☆
Cost & transparency	★★★★☆
Customer support	★☆☆☆☆

Pros	Cons
✅ Transparent competitive pricing	❌ Prescribers are pharmacists, not physicians
✅ Prescribers with weight-loss expertise	❌ Costs rise with higher doses
✅ Monthly consultations for safe dose adjustments	❌ No insurance accepted
✅ 24/7 patient support	❌ Slow or absent support
✅ Access to support group and educational resources	❌ No lifestyle coaching or app
✅ Medications for side-effect management included when needed	❌ Not available in the US

What Is myBMI?

myBMI is a UK-regulated online clinic focused entirely on weight loss. It prescribes brand-name GLP-1s Wegovy and Mounjaro and partners with a licensed UK pharmacy for dispensing.

Care comes from prescribing pharmacists who specialise in weight management. Insurance isn’t accepted, but each package includes consultation, medication, and treatments for common side effects.

What sets myBMI apart is its mix of medication, education, and community support. No apps or flashy coaching, just a focused service built for people serious about results. Still, in a market defined by the Price-Safety Trap, what comes next will show if myBMI escapes it.

How Does myBMI Work?

myBMI runs on a simple principle: safe, structured treatment guided by specialists. Every step is designed to check your health, prescribe the right GLP-1, and adjust it responsibly. The process repeats each month, so your progress and side effects are never ignored.

Step 1: Create Your Account and Verify ID

Start by creating an account and entering your details. You need to upload a photo of yourself holding an approved identity document, either a birth certificate, full or provisional driving licence, or a UK/EU passport.

myBMI verifies this with third-party services before moving your consultation forward.

Step 2: Complete Your Online Consultation

Fill in a health questionnaire about goals and medical history. You can indicate a treatment preference, but the final decision rests with the prescribing specialist based on your clinical profile.

Step 3: Specialist Review and Prescription

A weight-management prescribing pharmacist reviews your record and either approves treatment or denies it. If myBMI decides treatment is not suitable, your request is rejected and you are not charged.

Step 4: Payment and Pharmacy Dispensing

Once approved and paid, the partner pharmacy aims to process your prescription within 24–48 hours. myBMI’s packages include the monthly consultation and prescription.

Step 5: Cold-Chain Delivery to Your Door

Your medication ships from a licensed UK pharmacy in temperature-controlled packaging designed to stay within range for up to 48 hours. You receive a delivery window and need to be home, since a missed hand-off can break the cold chain.

Step 6: Monthly Check-Ins and Titration

Each plan covers 28 days. Before your next month, complete a short returning-patient consultation so the prescriber can monitor progress, adjust dose, and, if needed, add side-effect treatments.

A monthly consultation is required before each prescription. Patients also have access to ongoing education and a support community for additional guidance between consultations.

Treatment Options at myBMI

myBMI focuses exclusively on GLP-1 treatments for weight loss, offering brand-name medications prescribed through its licensed UK pharmacy.

Each plan runs on a 28-day cycle with medical oversight and ongoing access to educational resources and community support.

• Weekly injectables: Wegovy (semaglutide) and Mounjaro (tirzepatide)
• Guidance: educational content, Q&A sessions with prescribing pharmacists, and a private community for patients

Daily oral tablet formats are also mentioned on myBMI’s site, though they aren’t listed in active treatment plans.

Despite contacting the clinic twice, I couldn’t confirm current availability. The clinic’s official page lists orforglipron, a once-daily oral GLP-1, is shown as “coming soon”.

GLP-1 medications can cause side effects such as nausea or diarrhea, and myBMI provides additional treatments to help manage them.^[1] These are included in treatment plans when necessary, but the specific options aren’t listed publicly, and my attempts to confirm details went unanswered.

All medications are dispensed by Chemist4U, a General Pharmaceutical Council (GPhC)-registered pharmacy in Lancashire. The pharmacy maintains full regulatory compliance, uses cold-chain delivery for GLP-1s, and ensures every prescription is handled under UK dispensing standards.

myBMI Pricing: Higher Doses, Higher Costs

myBMI keeps its pricing simple to follow, though not flat. You pay for a 28-day treatment plan that includes your consultation, prescription, and medication. There is no separate membership or subscription fee. Prices increase as your GLP-1 dose rises, which is standard for brand-name injectables like Wegovy and Mounjaro.

• Wegovy:
  • £99 for 0.25 mg
  • £109 for 0.5 mg
  • £119 for 1 mg
  • £169 for 1.7 mg
  • £199 for 2.4 mg

• Mounjaro:
  • £178 for 2.5 mg
  • £198 for 5 mg 
  • £248 for 7.5 mg
  • £278 for 10 mg
  • £298 for 12.5 mg
  • £308 for 15 mg

Good to know: Like other GLP-1 medications, Wegovy and Mounjaro, are prescribed in gradually increasing doses, a process known as titration. You start on a low dose to let your body adjust and reduce side effects, then step up every four weeks until you reach the level that provides the most consistent results.^[2]

Each 28-day plan includes everything you’ll need for treatment, and then some:

• Initial consultation and prescription
• Ongoing pharmacist review
• Access to educational resources and patient community
• Side-effect management medications when needed
• Free delivery for single doses (£8.95 for multi-month bundles)

myBMI does not accept insurance, and there is no long-term commitment. Patients renew monthly after completing a short check-in and can cancel any time before the next order ships. Prices may change depending on manufacturer supply or national demand.

Overall, I find myBMI’s pricing model fair and straightforward. Each plan covers what really matters: consultation, prescription, and medication, without hidden add-ons. The cost does rise as doses increase, but I appreciate the transparency and inclusivity. What’s missing, though, is any long-term coaching or support for lasting change.

How myBMI Compares

myBMI takes a different route from most of the clinics we review. As a UK-based provider, it focuses on brand-name GLP-1 care through pharmacist-led prescribing rather than physician-run telehealth.

To help you understand where it fits, I’ve compared it with several leading US clinics, each built around a distinct philosophy.

• Shed focuses on adaptability and access. Patients can choose between Wegovy, Zepbound, or compounded GLP-1 lozenges, drops, or injections and have the option to add premium coaching for personalized guidance. Its mix of flexibility, competitive pricing, and optional accountability makes it a strong contender, though it still lacks insurance support.
• Henry Meds keeps things clinical and focused. Like myBMI, it offers straightforward medication management without coaching or an app, but it leans more on medical rigor with licensed providers and included lab testing.
• WeightWatchers builds around behavior first. Its foundation is habit change, community engagement, and ongoing workshops, with GLP-1 prescriptions added as a complementary tool rather than the centerpiece. It’s best suited for people who want long-term structure and lifestyle accountability alongside medication.

Each clinic takes its own route. myBMI stands out for its regulation and brand-name reliability but leaves out lifestyle support and tech-based tools. It’s a simple, credible choice for UK patients who want structure and safety over extra features.

Price & Trust Transparency Score™: C

Our surveys show a familiar trend. Unfortunately, 57% percent of people can’t find weight-loss care that feels affordable, and 32% still don’t know which clinics to trust. We call this the Price-Safety Trap, the gap between cost and confidence.

The Price & Trust Transparency Score looks at how clinics bridge that gap through fairness, safety, and follow-up. myBMI lands somewhere in the middle, a regulated UK provider that shows promise on pricing but stumbles on communication and consistency.

Category	Grade	Why it matters
True cost analysis	B	myBMI’s pricing is open and predictable, with all consultations and prescriptions included in the treatment cost. Still, prices rise with higher doses, and while that’s expected for brand-name GLP-1s, it means long-term affordability depends on your response to medication.
Safety & legitimacy	C	Prescriptions come from licensed pharmacists with weight-loss expertise, not physicians. myBMI’s partnership with a GPhC-registered pharmacy supports legitimacy, but the lack of clarity around lab work requirements and side-effect medications raises questions about oversight depth.
Long-term success	C	The clinic offers education and a community forum, yet no structured coaching or personalised lifestyle support. Combined with inconsistent customer communication, this weakens long-term accountability for patients staying on treatment safely and effectively.

myBMI shows solid regulatory grounding and fair pricing, but the communication gap and limited transparency around safety protocols keep it from earning higher marks. In a landscape where trust is built on clarity, silence counts as a red flag.

Lab Testing: What Gets Measured and Why It Matters

Lab testing plays an important role in safe GLP-1 treatment. These medications can affect blood sugar levels and fat metabolism, so most clinics check a few key markers before or during treatment to track safety and progress.^[3]

Typical markers often reviewed by GLP-1 clinics include the following:

• A1C (Hemoglobin A1C): measures average blood sugar levels over 2–3 months to detect insulin resistance or prediabetes
• Fasting glucose: provides a snapshot of current blood sugar control
• Lipid panel: tracks cholesterol and triglycerides, which often improve with weight loss
• Kidney function (creatinine, BUN): important because dehydration from vomiting or diarrhea can strain the kidneys
• Liver enzymes (ALT, AST): helps identify preexisting liver issues that could complicate treatment
• TSH (thyroid-stimulating hormone): screens for thyroid conditions that can mimic weight gain
• Electrolytes and CBC (complete blood count): offer a broader view of general health and any imbalances

While many clinics include or recommend baseline labs, myBMI does not clearly specify whether lab testing is required or included. I reached out twice for clarification about how often labs are done, whether they’re covered in pricing, or if they must be completed locally. Unfortunately, I did not receive a response.

Keep in mind: For patients starting GLP-1 therapy, this lack of clarity matters. Regular lab work can be an important safeguard, especially for those with metabolic or cardiovascular conditions.

🎯Who Should Use myBMI?

✔ Reliable regulation makes myBMI a strong choice for UK patients who want legitimate GLP-1 care.

Every prescription comes from licensed pharmacists and is filled by a GPhC-registered pharmacy, offering safety without unnecessary complexity.

✔ Inclusive pricing suits anyone who wants costs to stay predictable.

Each 28-day plan includes the consultation, prescription, and medication, so there are no hidden fees; only gradual increases as your dose rises.

✔ Independent patients do well here because myBMI keeps things focused.

Education and community support are available, but lifestyle coaching and daily accountability remain in your own hands.

🚫Who Is myBMI Not For?

Patients seeking doctor-led care or full medical screening may find the intake too light. Prescriptions are issued by pharmacists, and myBMI does not clearly state whether labs or baseline tests are part of its process.

Additionally, those who need structured coaching could feel unsupported, since there’s no dedicated app, no personal nutrition plan, and no one-on-one behavioral guidance.

Anyone expecting reliable communication might be disappointed by inconsistent or delayed responses that make it difficult to get quick answers about treatment or next steps.

Those hoping to use insurance will be disappointed. All plans require direct payment each month—insurance coverage is not accepted.

Finally, people outside the UK won’t find access here. myBMI serves UK residents only and does not currently ship or prescribe internationally.

How Does myBMI Compare to Other Clinics?

Here’s how myBMI’s regulated, pharmacist-led care fits among today’s most popular GLP-1 programs, from fast-access start-ups to full-service coaching clinics:

Swipe to scroll the table below →

Clinic	Best for	Monthly cost	Treatment options	Lab work	Add-ons	Insurance
myBMI	UK-based access to GLP-1 care	Meds only (£90–£308)	Wegovy; Mounjaro	Not stated	None	No
Shed	Results-driven users seeking affordable care	Meds only ($199–$499)	Wegovy; Zepbound; compounded semaglutide and tirzepatide (oral options available for both)	Not required	Optional coaching ($49.99)	No
Henry Meds	Quick-start care with med flexibility	Meds only ($149–$449)	Compounded liraglutide; semaglutide; tirzepatide (oral)	Included	None	No
Weight Watchers	Behavior- first approach	From $74 + cost of meds	Ozempic; Wegovy; Zepbound; Mounjaro; Saxenda®; Rybelsus®	Not included	Optional workshops (from $22/mo)	Yes (meds only)
Remedy Meds	Fast, inclusive access with flat pricing	Meds only ($299–$399)	Compounded semaglutide and tirzepatide (brand-name options may be prescribed)	Included	None	No
Found	Users looking for coaching and peer support	$129/mo or $39/mo with insurance + cost of meds	Ozempic; Wegovy; Zepbound; Mounjaro; Saxenda; Trulicity®; Victoza®; Rybelsus; compounded semaglutide	Not included	None	Yes
Calibrate	Insurance- supported, structured care	$199 (3-month commitment) + cost of meds	Ozempic; Wegovy; Mounjaro; Zepbound; Saxenda, Trulicity; Rybelsus	Not included	None	Yes (meds only)

Real User Experience With myBMI

myBMI has a 4.2-star rating from over 1,000 reviews on Trustpilot, earning a “Great” overall score. Most feedback comes from satisfied patients who describe the service as straightforward, supportive, and professionally handled. Still, a noticeable group of low-star reviews raises concerns about communication and delayed responses.

Many users praise myBMI for quick delivery, reliable prescriptions, and feeling cared for by professionals who understand weight loss treatment. One reviewer shared how timely guidance and side-effect support made the process reassuring and effective.

Yet not everyone reports the same experience. Several users mention long waits for replies or missing confirmations after placing orders. One reviewer even described weeks without updates or contact options after their order failed to arrive, a frustration echoed by others who struggled to reach support.

Overall, most patients find myBMI dependable once treatment begins, but communication remains its weak spot. My own experience matched what many users describe; I reached out twice over two weeks with clarification questions and never received a reply.

For a clinic built on trust and safety, that silence speaks loudly. Until myBMI strengthens its communication, its reliability on paper will not fully match the confidence patients expect in practice.

Final Verdict

myBMI offers legitimate, UK-regulated GLP-1 care with brand-name options, clear pricing, and monthly pharmacist oversight. It’s a safe, structured program that includes side-effect support and educational resources for steady progress.

However, limited lifestyle guidance and unresponsive communication hold it back. My own experience reaching out for clarification went unanswered, raising concerns about reliability.

For those seeking straightforward, medication-first care, myBMI delivers on safety and transparency but needs stronger patient communication to match.

👉 See If myBMI Is Right for You

FAQs

---

Disclaimer: This review is for informational purposes only and does not constitute medical advice. Always consult a licensed healthcare provider before starting or changing hormone therapy.

---

Recent Updates

• November 21, 2025: Updated Shed information to include the addition of Wegovy and Zepbound to available treatments and updated the price of optional coaching.

Sources

1. Ismaiel, A., Scarlata, G. G. M., Boitos, I., Leucuta, D.-C., Popa, S.-L., Al Srouji, N., Abenavoli, L., & Dumitrascu, D. L. (2025). Gastrointestinal adverse events associated with GLP-1 RA in non-diabetic patients with overweight or obesity: A systematic review and network meta-analysis. International Journal of Obesity. https://doi.org/10.1038/s41366-025-01859-6
2. Michelet, A., Mowla, M., Amo-Brown, B. A., Rodriguez, N., & Cavaretta, M. (2025). Missed doses, missed opportunities: Readmission due to GLP-1RA interruption inspires algorithms to improve reinitiation of therapy at discharge. Hospital Pharmacy, 00185787251372054. https://doi.org/10.1177/00185787251372054
3. Zheng, Z., Zong, Y., Ma, Y., Tian, Y., Pang, Y., Zhang, C., & Gao, J. (2024). Glucagon-like peptide-1 receptor: Mechanisms and advances in therapy. Signal Transduction and Targeted Therapy, 9(1). https://doi.org/10.1038/s41392-024-01931-z
4. Cai, W., Zhang, R., Yao, Y., Wu, Q., & Zhang, J. (2024). Tirzepatide as a novel effective and safe strategy for treating obesity: A systematic review and meta-analysis of randomized controlled trials. Frontiers in Public Health, 12. https://doi.org/10.3389/fpubh.2024.1277113